Kidney transplantation using complement inhibitor in a patient suffering from atypical hemolytic-uremic syndrome associated with factor H antibodies: successful prevention of recurrence of the underlying disease

Atypical hemolytic-uremic syndrome (aHUS) is an extremely rare complement-mediated disease that belongs to the group of thrombotic microangiopathies (TMA). It often reoccurs after kidney transplantation (KT). Previously, KT was considered contraindicated in both children and adults with aHUS due to...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: E. I. Prokopenko, S. A. Pasov, A. V. Vatazin, A. Ya. Tsalman, T. E. Pankratenko, G. A. Generalova
Formato: Artigo
Lenguaje:Russo
Publicado: Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov 2020-07-01
Colección:Vestnik Transplantologii i Iskusstvennyh Organov
Materias:
atypical hemolytic-uremic syndrome
eculizumab
kidney transplantation
complement-activating conditions
Acceso en línea:https://journal.transpl.ru/vtio/article/view/1194
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares